Open original FDA record ↗Recall record
- FDA identifier
- Z-1687-2018
- Company in FDA record
- Siemens Healthcare Diagnostics, Inc.
- FDA classification date
- May 4, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The concentrations for biotin listed in the non-interfering substances section of the instructions for use for the Dimension TSHL, Dimension LOCI FT4L, Dimension Vista TSH, ADVIA Centaur Cyclosporine, and ADVIA Centaur DHEAS, incorrectly state the level at which biotin does not interfere
Source facts
- Action
- Siemens Healthcare Diagnostics issued a recall in March 2017 for products with incorrect units for biotin in the Instructions for Use. After further investigation, recalling firm determined that more Siemens products also had missing or incorrect information in the IFUs for which two recalls were initiated, and Amended Corrections and Removals Reports were submitted to the FDA
- Initiated
- 2018-01-02
- Root cause
- Error in labeling
- Terminated
- 2023-02-10
- Distribution
- Nationwide and Canada, Mexico, and Thailand
- Recall number
- Z-1687-2018
- Recall status
- Terminated
- CDRH record ID
- 162522
- FDA classified
- 2018-05-04
- Recall event number
- 79505